vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $141.8M, roughly 1.2× BLACKBERRY Ltd). BLACKBERRY Ltd runs the higher net margin — 9.7% vs -82.0%, a 91.6% gap on every dollar of revenue. On growth, BLACKBERRY Ltd posted the faster year-over-year revenue change (-0.8% vs -22.7%). BLACKBERRY Ltd produced more free cash flow last quarter ($17.4M vs $-36.6M). Over the past eight quarters, BLACKBERRY Ltd's revenue compounded faster (17.8% CAGR vs -11.5%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

BB vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.2× larger
PTCT
$164.7M
$141.8M
BB
Growing faster (revenue YoY)
BB
BB
+21.9% gap
BB
-0.8%
-22.7%
PTCT
Higher net margin
BB
BB
91.6% more per $
BB
9.7%
-82.0%
PTCT
More free cash flow
BB
BB
$54.0M more FCF
BB
$17.4M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
BB
BB
Annualised
BB
17.8%
-11.5%
PTCT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
PTCT
PTCT
Revenue
$141.8M
$164.7M
Net Profit
$13.7M
$-135.0M
Gross Margin
77.5%
Operating Margin
8.4%
-43.3%
Net Margin
9.7%
-82.0%
Revenue YoY
-0.8%
-22.7%
Net Profit YoY
224.5%
-104.8%
EPS (diluted)
$0.02
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
PTCT
PTCT
Q4 25
$141.8M
$164.7M
Q3 25
$129.6M
$211.0M
Q2 25
$121.7M
$178.9M
Q1 25
$141.7M
$1.2B
Q4 24
$143.6M
$213.2M
Q3 24
$126.2M
$196.8M
Q2 24
$123.4M
$186.7M
Q1 24
$102.1M
$210.1M
Net Profit
BB
BB
PTCT
PTCT
Q4 25
$13.7M
$-135.0M
Q3 25
$13.3M
$15.9M
Q2 25
$1.9M
$-64.8M
Q1 25
$-7.4M
$866.6M
Q4 24
$-10.5M
$-65.9M
Q3 24
$-19.7M
$-106.7M
Q2 24
$-41.4M
$-99.2M
Q1 24
$-56.2M
$-91.6M
Gross Margin
BB
BB
PTCT
PTCT
Q4 25
77.5%
Q3 25
74.5%
Q2 25
74.2%
Q1 25
73.5%
Q4 24
78.1%
Q3 24
70.2%
Q2 24
72.9%
Q1 24
Operating Margin
BB
BB
PTCT
PTCT
Q4 25
8.4%
-43.3%
Q3 25
8.9%
1.4%
Q2 25
1.6%
-19.5%
Q1 25
-5.6%
82.5%
Q4 24
13.6%
-76.2%
Q3 24
1.7%
-27.7%
Q2 24
-10.5%
-21.5%
Q1 24
50.0%
-21.6%
Net Margin
BB
BB
PTCT
PTCT
Q4 25
9.7%
-82.0%
Q3 25
10.3%
7.5%
Q2 25
1.6%
-36.3%
Q1 25
-5.2%
73.7%
Q4 24
-7.3%
-30.9%
Q3 24
-15.6%
-54.2%
Q2 24
-33.5%
-53.1%
Q1 24
-55.0%
-43.6%
EPS (diluted)
BB
BB
PTCT
PTCT
Q4 25
$0.02
$-1.63
Q3 25
$0.02
$0.20
Q2 25
$0.00
$-0.83
Q1 25
$-0.01
$10.04
Q4 24
$-0.02
$-0.85
Q3 24
$-0.03
$-1.39
Q2 24
$-0.07
$-1.29
Q1 24
$-0.08
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$304.2M
$1.9B
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$-205.3M
Total Assets
$1.2B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
PTCT
PTCT
Q4 25
$304.2M
$1.9B
Q3 25
$290.5M
$1.7B
Q2 25
$306.6M
$2.0B
Q1 25
$337.8M
$2.0B
Q4 24
$220.0M
$1.1B
Q3 24
$211.0M
$1.0B
Q2 24
$229.0M
$1.1B
Q1 24
$237.1M
$884.8M
Total Debt
BB
BB
PTCT
PTCT
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Q1 24
$194.1M
Stockholders' Equity
BB
BB
PTCT
PTCT
Q4 25
$741.1M
$-205.3M
Q3 25
$725.1M
$-155.8M
Q2 25
$725.1M
$-206.5M
Q1 25
$719.9M
$-185.8M
Q4 24
$725.2M
$-1.1B
Q3 24
$732.1M
$-1.1B
Q2 24
$742.6M
$-980.2M
Q1 24
$775.1M
$-893.9M
Total Assets
BB
BB
PTCT
PTCT
Q4 25
$1.2B
$2.9B
Q3 25
$1.2B
$2.6B
Q2 25
$1.2B
$2.6B
Q1 25
$1.3B
$2.7B
Q4 24
$1.3B
$1.7B
Q3 24
$1.3B
$1.8B
Q2 24
$1.3B
$1.9B
Q1 24
$1.4B
$1.8B
Debt / Equity
BB
BB
PTCT
PTCT
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
PTCT
PTCT
Operating Cash FlowLast quarter
$18.3M
$-34.3M
Free Cash FlowOCF − Capex
$17.4M
$-36.6M
FCF MarginFCF / Revenue
12.3%
-22.3%
Capex IntensityCapex / Revenue
0.6%
1.4%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$42.8M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
PTCT
PTCT
Q4 25
$18.3M
$-34.3M
Q3 25
$3.9M
$-66.3M
Q2 25
$-18.0M
$-58.3M
Q1 25
$41.6M
$870.1M
Q4 24
$6.0M
$-30.0M
Q3 24
$-16.0M
$-77.0M
Q2 24
$-15.1M
$-71.5M
Q1 24
$-15.5M
$70.8M
Free Cash Flow
BB
BB
PTCT
PTCT
Q4 25
$17.4M
$-36.6M
Q3 25
$3.1M
$-69.7M
Q2 25
$-18.9M
$-59.6M
Q1 25
$41.2M
$868.4M
Q4 24
$5.2M
$-33.8M
Q3 24
$-16.5M
$-77.5M
Q2 24
$-16.5M
$-78.8M
Q1 24
$-17.6M
$61.2M
FCF Margin
BB
BB
PTCT
PTCT
Q4 25
12.3%
-22.3%
Q3 25
2.4%
-33.1%
Q2 25
-15.5%
-33.3%
Q1 25
29.1%
73.8%
Q4 24
3.6%
-15.8%
Q3 24
-13.1%
-39.4%
Q2 24
-13.4%
-42.2%
Q1 24
-17.2%
29.1%
Capex Intensity
BB
BB
PTCT
PTCT
Q4 25
0.6%
1.4%
Q3 25
0.6%
1.6%
Q2 25
0.7%
0.7%
Q1 25
0.3%
0.1%
Q4 24
0.6%
1.8%
Q3 24
0.4%
0.3%
Q2 24
1.1%
4.0%
Q1 24
2.1%
4.6%
Cash Conversion
BB
BB
PTCT
PTCT
Q4 25
1.34×
Q3 25
0.29×
-4.17×
Q2 25
-9.47×
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons